Sort   by:  
 Page size 
It is well established that Staphylococcus aureus can incorporate exogenous straight-chain unsaturated fatty acids (SCUFAs) into membrane phospho- and glyco-lipids from various sources in supplemented culture media, and when growing in vivo in an infection. Given the enhancement of membrane fluidity...
ORGANISM(S): Staphylococcus Aureus (ncbitaxon:1280) 
2024-05-10 | MSV000094738 | GNPS
Methicillin resistance in Staphylococcus aureus depends on the production of mecA, which encodes penicillin-binding protein 2A (PBP2A), an acquired peptidoglycan transpeptidase with reduced susceptibility to beta-lactam antibiotics. Here, we show that preventing the expression of wall teichoic acids...
ORGANISM(S): Staphylococcus aureus 
Daptomycin is a membrane-targeting last-resort antimicrobial therapeutic for the treatment of infections caused by methicillin- and/or vancomycin-resistant Staphylococcus aureus. In the rare event of failed daptomycin therapy, the source of resistance is often attributable to mutations directly with...
ORGANISM(S): Staphylococcus Aureus (ncbitaxon:1280) 
2023-04-12 | MSV000091690 | GNPS
Up to 80% of the fatty acids in Staphylococcus aureus membrane lipids are branched, rather than straight-chain, fatty acids. The branched fatty acids (BCFAs) may have either an even or odd number of carbons and the branch position may be at the penultimate carbon (iso) or the antepenultimate (anteis...
ORGANISM(S): Staphylococcus Aureus 
2021-05-03 | MSV000087356 | GNPS
Sort   by:  
 Page size